Abstract
Loss of either NEDD9 or BCL-XL confers hypersensitivity to PI3K-alpha inhibition whereas loss of CBFB confers resistance through a CBFB/PIM1 signaling axis.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have